View in EDS HTML Full Text PDF Full Text

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer.
Authors: Hoang VT; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Matossian MD; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Ucar DA; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Elliott S; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., La J; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Wright MK; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Burks HE; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Perles A; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States., Hossain F; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States., King CT; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States., Browning VE; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States., Bursavich J; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States., Fang F; Medical Sciences, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States., Del Valle L; Department of Pathology, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Bhatt AB; Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States., Cavanaugh JE; Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States., Flaherty PT; Department of Medicinal Chemistry, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States., Anbalagan M; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States., Rowan BG; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States., Bratton MR; Cellular and Molecular Biology Core, Xavier University, New Orleans, LA, United States., Nephew KP; Medical Sciences, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States., Miele L; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Collins-Burow BM; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane Cancer Center, New Orleans, LA, United States., Martin EC; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States., Burow ME; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, United States.
Source: Frontiers in oncology [Front Oncol] 2020 Aug 03; Vol. 10, pp. 1164. Date of Electronic Publication: 2020 Aug 03 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32850332
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hoang+VT%22">Hoang VT</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Matossian+MD%22">Matossian MD</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Ucar+DA%22">Ucar DA</searchLink>; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Elliott+S%22">Elliott S</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22La+J%22">La J</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Wright+MK%22">Wright MK</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Burks+HE%22">Burks HE</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Perles+A%22">Perles A</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Hossain+F%22">Hossain F</searchLink>; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22King+CT%22">King CT</searchLink>; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States.<br /><searchLink fieldCode="AU" term="%22Browning+VE%22">Browning VE</searchLink>; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States.<br /><searchLink fieldCode="AU" term="%22Bursavich+J%22">Bursavich J</searchLink>; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States.<br /><searchLink fieldCode="AU" term="%22Fang+F%22">Fang F</searchLink>; Medical Sciences, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States.<br /><searchLink fieldCode="AU" term="%22Del+Valle+L%22">Del Valle L</searchLink>; Department of Pathology, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Bhatt+AB%22">Bhatt AB</searchLink>; Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Cavanaugh+JE%22">Cavanaugh JE</searchLink>; Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Flaherty+PT%22">Flaherty PT</searchLink>; Department of Medicinal Chemistry, School of Pharmacy, Duquesne University, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Anbalagan+M%22">Anbalagan M</searchLink>; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Rowan+BG%22">Rowan BG</searchLink>; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Bratton+MR%22">Bratton MR</searchLink>; Cellular and Molecular Biology Core, Xavier University, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Nephew+KP%22">Nephew KP</searchLink>; Medical Sciences, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States.<br /><searchLink fieldCode="AU" term="%22Miele+L%22">Miele L</searchLink>; Department of Genetics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Collins-Burow+BM%22">Collins-Burow BM</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane Cancer Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Martin+EC%22">Martin EC</searchLink>; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, United States.<br /><searchLink fieldCode="AU" term="%22Burow+ME%22">Burow ME</searchLink>; Section of Hematology & Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, United States.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2020 Aug 03; Vol. 10, pp. 1164. <i>Date of Electronic Publication: </i>2020 Aug 03 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32850332
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2020.01164
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1164
    Titles:
      – TitleFull: ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hoang VT
      – PersonEntity:
          Name:
            NameFull: Matossian MD
      – PersonEntity:
          Name:
            NameFull: Ucar DA
      – PersonEntity:
          Name:
            NameFull: Elliott S
      – PersonEntity:
          Name:
            NameFull: La J
      – PersonEntity:
          Name:
            NameFull: Wright MK
      – PersonEntity:
          Name:
            NameFull: Burks HE
      – PersonEntity:
          Name:
            NameFull: Perles A
      – PersonEntity:
          Name:
            NameFull: Hossain F
      – PersonEntity:
          Name:
            NameFull: King CT
      – PersonEntity:
          Name:
            NameFull: Browning VE
      – PersonEntity:
          Name:
            NameFull: Bursavich J
      – PersonEntity:
          Name:
            NameFull: Fang F
      – PersonEntity:
          Name:
            NameFull: Del Valle L
      – PersonEntity:
          Name:
            NameFull: Bhatt AB
      – PersonEntity:
          Name:
            NameFull: Cavanaugh JE
      – PersonEntity:
          Name:
            NameFull: Flaherty PT
      – PersonEntity:
          Name:
            NameFull: Anbalagan M
      – PersonEntity:
          Name:
            NameFull: Rowan BG
      – PersonEntity:
          Name:
            NameFull: Bratton MR
      – PersonEntity:
          Name:
            NameFull: Nephew KP
      – PersonEntity:
          Name:
            NameFull: Miele L
      – PersonEntity:
          Name:
            NameFull: Collins-Burow BM
      – PersonEntity:
          Name:
            NameFull: Martin EC
      – PersonEntity:
          Name:
            NameFull: Burow ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 08
              Text: 2020 Aug 03
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1